LANCASTER,Pa.,Sept. 11,2024--NewEnergyBlue,the clean-technology designer of biomass refineries that turn agricultural waste into highly decarbonized biofuels and biochemicals,has finalized its purchas
HANGZHOU,China,Sept. 11,2024-- On September 5th,Lynk & Co officially announced the launch of the brand\'s first all-electric model,Lynk & Co Z10. Built on the world-class intelligent electric
HONG KONG,Sept. 11,2024-- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK),a leading enterprise and marketing cloud platform in China that empowers
SAN FRANCISCO and SUZHOU,China,Sept. 12,2024-- Innovent Biologics,Inc. (Innovent) (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-quality medic
KUALA LUMPUR,Malaysia,Sept. 12,2024-- Oil and Gas Asia (OGA), the leading industry event for the oil,gas,energy and petrochemicals sector in Southeast Asia,is set to welcome a pivotal gathering of en
BERLIN,Sept. 10,2024-- RingConn,a leading personal health technology company,recently showcased its newest innovation—the RingConn Gen 2 Smart Ring—at IFA 2024. This groundbreaking device is the fir
ZHAOYUAN,China,Sept. 10,2024-- On September 9,Linglong Tire,a Chinese leading tire manufacturing company,officially announced a multi-year agreement with Chelsea Football Club,one of the world\'s most
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
